AU2010264067A1 - A method and system for the detection of cancer - Google Patents

A method and system for the detection of cancer Download PDF

Info

Publication number
AU2010264067A1
AU2010264067A1 AU2010264067A AU2010264067A AU2010264067A1 AU 2010264067 A1 AU2010264067 A1 AU 2010264067A1 AU 2010264067 A AU2010264067 A AU 2010264067A AU 2010264067 A AU2010264067 A AU 2010264067A AU 2010264067 A1 AU2010264067 A1 AU 2010264067A1
Authority
AU
Australia
Prior art keywords
antigen
antigens
cancer
sample
relative contribution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2010264067A
Other languages
English (en)
Other versions
AU2010264067A2 (en
Inventor
Alon Hayka
Galit Yahalom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eventus Diagnostics Israel Ltd
Original Assignee
Eventus Diagnostics Israel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eventus Diagnostics Israel Ltd filed Critical Eventus Diagnostics Israel Ltd
Publication of AU2010264067A1 publication Critical patent/AU2010264067A1/en
Publication of AU2010264067A2 publication Critical patent/AU2010264067A2/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/10—Complex mathematical operations
    • G06F17/18—Complex mathematical operations for evaluating statistical data, e.g. average values, frequency distributions, probability functions, regression analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/30—Detection of binding sites or motifs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Theoretical Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Data Mining & Analysis (AREA)
  • Mathematical Physics (AREA)
  • Mathematical Analysis (AREA)
  • Mathematical Optimization (AREA)
  • Computational Mathematics (AREA)
  • Pure & Applied Mathematics (AREA)
  • Operations Research (AREA)
  • Probability & Statistics with Applications (AREA)
  • Algebra (AREA)
AU2010264067A 2009-06-23 2010-06-23 A method and system for the detection of cancer Abandoned AU2010264067A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21953909P 2009-06-23 2009-06-23
US61/219,539 2009-06-23
PCT/IL2010/000498 WO2010150254A2 (en) 2009-06-23 2010-06-23 A method and system for the detection of cancer

Publications (2)

Publication Number Publication Date
AU2010264067A1 true AU2010264067A1 (en) 2012-01-19
AU2010264067A2 AU2010264067A2 (en) 2012-08-30

Family

ID=42710569

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010264067A Abandoned AU2010264067A1 (en) 2009-06-23 2010-06-23 A method and system for the detection of cancer

Country Status (7)

Country Link
US (1) US20120202226A1 (enExample)
EP (1) EP2446272A2 (enExample)
JP (1) JP2012531581A (enExample)
KR (1) KR20120098992A (enExample)
AU (1) AU2010264067A1 (enExample)
SG (1) SG176962A1 (enExample)
WO (1) WO2010150254A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108290622B (zh) 2015-12-30 2020-07-17 现代重工业株式会社 液化气体运输船
US11544582B2 (en) * 2016-02-02 2023-01-03 Ambertag, Inc. Predictive modelling to score customer leads using data analytics using an end-to-end automated, sampled approach with iterative local and global optimization
KR102437995B1 (ko) * 2016-03-07 2022-08-29 에프. 호프만-라 로슈 아게 항-p53 항체의 검출
EP3589959B1 (en) 2017-03-01 2022-09-07 Roche Diagnostics GmbH Systems, method and computer-readable medium for classifying a biological sample regarding the presence of an analyte
US11804298B2 (en) 2017-07-17 2023-10-31 Joon Kim Cancer diagnostic apparatus and cancer diagnostic system using the same
KR102007664B1 (ko) * 2017-07-17 2019-08-07 김준 암 진단기 및 이를 이용한 암 진단시스템
EP3527989B1 (en) 2018-02-18 2020-11-25 Lidia Márquez Márquez Method, device and kit for the early detection of breast cancer
JP7157941B2 (ja) * 2020-08-05 2022-10-21 憲一 佐藤 癌罹患判定方法、装置、およびプログラム

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810040D0 (en) * 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
WO2000061636A2 (en) * 1999-04-14 2000-10-19 Research Corporation Technologies, Inc. Aberrantly glycosylated antibodies as marker for cancer
AU2002257647A1 (en) * 2001-03-09 2002-09-24 Callistogen Ag Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination
EP1367395A1 (de) * 2002-05-02 2003-12-03 B.R.A.H.M.S Aktiengesellschaft Diagnose von Neoplasmen mit Hilfe von anti-Gangliosid-Antikörpern
GB2426581A (en) * 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
MX2008016352A (es) 2006-07-08 2009-04-17 Univ Kentucky Res Found Analisis diagnostico para cancer de pulmon.
CN101632020B (zh) * 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
WO2008032084A1 (en) * 2006-09-13 2008-03-20 Oncimmune Ltd Improved immunoassay methods
EP2223116B1 (en) * 2007-12-10 2014-11-19 Roche Diagnostics GmbH Marker panel for colorectal cancer

Also Published As

Publication number Publication date
KR20120098992A (ko) 2012-09-06
JP2012531581A (ja) 2012-12-10
SG176962A1 (en) 2012-01-30
WO2010150254A2 (en) 2010-12-29
US20120202226A1 (en) 2012-08-09
WO2010150254A3 (en) 2011-10-06
AU2010264067A2 (en) 2012-08-30
EP2446272A2 (en) 2012-05-02

Similar Documents

Publication Publication Date Title
AU2010264067A1 (en) A method and system for the detection of cancer
JP6026422B2 (ja) 肺がん試験
US20100204055A1 (en) Autoantibody detection systems and methods
US20120231966A1 (en) Lung cancer diagnostic assay
CN108107218B (zh) 抗体测定
WO2006091734A9 (en) Compositions and methods for classifying biological samples
CN101490550A (zh) 肺癌诊断分析
CN112272773A (zh) 用于检测花生过敏的肽和方法
US20210318316A1 (en) Lung cancer protein epitomic biomarkers
AU2010252907A1 (en) Methods for the diagnosis or prognosis of colorectal cancer
Infantino et al. Current technologies for anti-ENA antibody detection: State-of-the-art of diagnostic immunoassays
JP7744641B2 (ja) 肺癌における自己抗体を検出するための抗原の組合せの使用
Liu et al. Using SELDI‐TOF MS to identify serum biomarkers of rheumatoid arthritis
WO2013166480A1 (en) Detectors of serum biomarkers for predicting ovarian cancer recurrence
CN118777605A (zh) 一种用于胰腺癌早期诊断的生物标志物及检验试剂盒
CN113933509A (zh) 抗体测定
WO2022173967A1 (en) Kits and methods for detecting markers and determining the presence or risk of cancer
CN116413430A (zh) 一种用于肝癌早期预测的自身抗体/抗原组合及检测试剂盒
GB2600701A (en) Antibody assay
CN118737428A (zh) 通过分子标志物表达量诊断复发性多软骨炎的系统、试剂盒
TW201928351A (zh) 抗體測定

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 30 JUL 2012

MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application